Yupeng Zheng

SLFN5 correlates with tumor immune microenvironment and clinical outcomes of immunotherapy in melanoma

Schlafen family member 5 (SLFN5) has been implicated in melanoma progression, but its expression landscape, immunomodulatory function, and prognostic value for patient survival remain poorly characterized. Here, we systematically analyzed multi-omics datasets, clinical cohorts, h...